期刊文献+

雷帕霉素对胰腺癌PC-2细胞增殖和凋亡的影响 被引量:1

Effects of Rapamycin in Suppressing Proliferation and Inducing Apoptosis of Pancreatic Cancer PC-2 Cells
下载PDF
导出
摘要 目的探讨雷帕霉素(RPM)对体外培养的胰腺癌PC-2细胞增殖和凋亡的影响。方法以10~50 nmol/L不同浓度RPM处理PC-2细胞,四甲基偶氮唑盐法检测不同浓度、不同时间RPM处理后的PC-2细胞生长情况;AnnexinV-FITC/PI双标记染色,流式细胞术检测肿瘤细胞凋亡情况;反转录-聚合酶链反应方法检测mTOR mRNA表达。结果不同浓度的RPM作用于PC-2细胞0~96 h后,对PC-2细胞的生长有明显的抑制作用,呈时间和浓度依赖性;流式细胞仪检测结果显示,10~50 nmol/L RPM均能诱导不同程度的细胞凋亡,且10~30 nmol/L RPM组以早期凋亡细胞为主,随着RPM浓度的增高,晚期凋亡细胞明显增多;反转录-聚合酶链反应结果显示,与空白对照组相比,药物处理组mRNA相对表达量均有不同程度的抑制效应,而且随着RPM浓度增高,mTOR mRNA水平表达逐渐降低,RPM与mTOR mRNA表达间表现出较好的剂量依赖性关系(P<0.05)。结论 RPM可有效抑制胰腺癌PC-2细胞增殖,并诱导细胞凋亡,其作用机制可能与下调mTOR基因表达有关。 Objective To investigate the effects of Rapamycin(RPM)in suppressing proliferation and inducing apoptosis of pancreatic carcinoma PC-2 cells in vitro.Methods MTT assay was used to examine the proliferation of PC-2 cells treated by different concentration(10-50 nmol/L)RPM after 0-96 hours.Flow cytometry was performed to analyze the apoptosis of PC-2 cells by staining with annexin V-FITC/PI.The expression of mTOR was measured by semi-quantitive reverse transcription polymerase chain reaction(RT-PCR)method.Results The inhibition of proliferation of PC-2 cells in vitro was observerd in time and dose dependent.Flow cytometry assay also showed RPM had positive effect on apoptosis.Cells treated with 10-30 nmol/L RPM are mainly composed of early apoptotic cells.While,cells treated with high dose RPM are mainly composed of late apoptotic cells.RPM could effectively down-regulate the expression of mTOR in the mRNA levels.The relative expression of mTOR to RPM was increased in a dose-dependent manner(P〈0.05).Conclusion RPM could effectively inhibit proliferation and induce apoptosis in PC-2 cells.The mechanism could be related to down-expression of mTOR.
出处 《医学综述》 2011年第18期2826-2829,共4页 Medical Recapitulate
基金 陕西省科技攻关项目(2010K01-138) 吴阶平医学基金会临床科研专项资助基金(320.6750.07132)
关键词 胰腺癌 雷帕霉素 MTOR 细胞凋亡 Pancreatic cancer Rapamycin Mammalian target of rapamycin Apoptosis
  • 相关文献

参考文献12

  • 1Mahalingam D,Sankhala K,Mita A,et al.Targeting the mTOR pathway using deforolimus in cancer therapy[J].Future Oncol,2009,5(3):291-303. 被引量:1
  • 2Zheng J,Hudder A,Zukowski K,et al.Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells[J].Cancer Lett,2010,296(1):74-87. 被引量:1
  • 3Castroagudín JF,Molina-Pérez E,Ferreiro-Iglesias R,et al.Strategies of immunosuppression for liver transplant recipients with hepatocellular carcinoma[J].Transplant Proc,2011,43(3):711-713. 被引量:1
  • 4Vemulapalli S,Mita A,Alvarado Y,et al.The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas[J].Target Oncol,2011,6(1):29-39. 被引量:1
  • 5Mansure JJ,Nassim R,Chevalier S,et al.Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer[J].Cancer Biol Ther,2009,8(24):2339-2347. 被引量:1
  • 6Guo Y,Liang X,Lu M,et al.Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma[J].Hepatogastroenterology,2010,57(101):913-918. 被引量:1
  • 7Garrido-Laguna I,Tan AC,Uson M,et al.Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer[J].Br J Cancer,2010,103(5):649-655. 被引量:1
  • 8Nagata Y,Takahashi A,Ohnishi K,et al.Effect of rapamycin,an mTOR inhibitor,on radiation sensitivity of lung cancer cells having different p53 gene status[J].Int J Oncol,2010,37(4):1001-1010. 被引量:1
  • 9Barger JF,Gallo CA,Torni KA,et al.Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin[J].Cancer Biol Ther,2011,10(12):1256-1261. 被引量:1
  • 10Huang S,Shu L,Dilling MB,et al.Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1)[J].J Mol Cell,2003,11(6):1491-1501. 被引量:1

同被引文献35

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部